Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lawsuit
Pharma
CMS, Incyte settle lawsuit on classification of Opzelura
Incyte has dropped a lawsuit against the CMS, as the agency has agreed not to classify Opzelura together with Jakafi.
Kevin Dunleavy
Jun 23, 2026 1:32pm
Genentech, Novartis accused of Xolair kickback scheme in lawsuit
Jun 23, 2026 8:25am
Lilly accuses church-linked firms of rebate fraud scheme
May 21, 2026 3:37pm
Jury awards $885M in Takeda pay-for-delay antitrust case
May 19, 2026 8:39am
SCOTUS temporarily restores telehealth access to abortion pill
May 15, 2026 11:20am
With FDA decision date looming, Capricor sues partner NS Pharma
May 8, 2026 11:38am
